{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:56:49Z","timestamp":1776218209395,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"DOI":"10.7759\/cureus.107063","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:03:43Z","timestamp":1776215023000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinico-Hematological and Immunophenotypic Profile of Leukemia Patients at a Tertiary Care Center in Jharkhand, India: A Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Abhirup","family":"Shome","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj K","family":"Paswan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anshu","family":"Jamaiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhimanyu","family":"Shome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Leukemia","author":"Chennamadhavuni A","year":"2026","unstructured":"Chennamadhavuni A, Iyengar V, Mukkamalla SKR, Shimanovsky A. Leukemia. StatPearls, Treasure Island (FL); 2026."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al.. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.904292","article-title":"Disease burden, risk factors, and trends of leukaemia: a global analysis","volume":"12","author":"Huang J","year":"2022","unstructured":"Huang J, Chan SC, Ngai CH, et al.. Disease burden, risk factors, and trends of leukaemia: a global analysis. Front Oncol. 2022, 12:904292. 10.3389\/fonc.2022.904292","journal-title":"Front Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000447076","article-title":"Leukemia","author":"Juliusson G","year":"2016","unstructured":"Juliusson G, Hough R. Leukemia. Progress in Tumor Research. Karger, Basel; 2016. 43:87-100. 10.1159\/000447076"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.62557","article-title":"Leukemia in India: insights into incidence, prevalence, mortality, and disability-adjusted life years","volume":"16","author":"Nalage DN","year":"2024","unstructured":"Nalage DN, Kudnar PS, Langhe R, et al.. Leukemia in India: insights into incidence, prevalence, mortality, and disability-adjusted life years. Cureus. 2024, 16:e62557. 10.7759\/cureus.62557","journal-title":"Cureus"},{"key":"ref6","unstructured":"Indian Council of Medical Research and National Centre for Disease Informatics and Research (ICMR-NCDIR). Population based cancer registry. (2026). Accessed: January 16, 2026: https:\/\/pbcr.ncdirindia.org\/pbcr_2.0\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.36255\/exon-publications-leukemia-who-5th-edition-hematolymphoid-tumors","article-title":"The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors","author":"Li W","year":"2022","unstructured":"Li W. The 5th Edition of the World Health Organization Classification of Hematolymphoid Tumors. Exon Publications, Brisbane; 2022. 10.36255\/exon-publications-leukemia-who-5th-edition-hematolymphoid-tumors"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2025-210135","article-title":"Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid\/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings","volume":"78","author":"Tembhare P","year":"2025","unstructured":"Tembhare P, Chen X, Chan JK, et al.. Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid\/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings. J Clin Pathol. 2025, 78:505-18. 10.1136\/jcp-2025-210135","journal-title":"J Clin Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-022-03430-4","article-title":"The International Consensus Classification of acute myeloid leukemia","volume":"482","author":"Weinberg OK","year":"2023","unstructured":"Weinberg OK, Porwit A, Orazi A, et al.. The International Consensus Classification of acute myeloid leukemia. Virchows Arch. 2023, 482:27-37. 10.1007\/s00428-022-03430-4","journal-title":"Virchows Arch"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757233","article-title":"Clinico-hematological profile of acute leukemia cases in Bihar: a multiparameter study in a tertiary-care hospital","volume":"15","author":"Shuchismita S","year":"2023","unstructured":"Shuchismita S, Jamal I, Raman RB, Choudhary V. Clinico-hematological profile of acute leukemia cases in Bihar: a multiparameter study in a tertiary-care hospital. J Lab Physicians. 2023, 15:84-9. 10.1055\/s-0042-1757233","journal-title":"J Lab Physicians"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1211_21","article-title":"Utility of flow cytometry in diagnosis of acute leukemias: a study at RIMS, Ranchi, India","volume":"11","author":"Mahto SK","year":"2022","unstructured":"Mahto SK, Prasad N. Utility of flow cytometry in diagnosis of acute leukemias: a study at RIMS, Ranchi, India. J Family Med Prim Care. 2022, 11:7335-8. 10.4103\/jfmpc.jfmpc_1211_21","journal-title":"J Family Med Prim Care"},{"key":"ref13","unstructured":"BD Biosciences. Homepage. (2024). Accessed: February 1, 2026: https:\/\/www.bdbiosciences.com."},{"key":"ref14","unstructured":"Indian Council of Medical Research. Standard operating procedures for immunophenotyping of hematolymphoid neoplasms. (2016). Accessed: March 26, 2026: https:\/\/www.icmr.gov.in\/icmrobject\/custom_data\/pdf\/resource-guidelines\/Immunophenotyping%20of%20Hematolymphoid%20Neop...."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20365","article-title":"2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications","volume":"72 Suppl 1","author":"Davis BH","year":"2007","unstructured":"Davis BH, Holden JT, Bene MC, et al.. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom. 2007, 72 Suppl 1:S5-13. 10.1002\/cyto.b.20365","journal-title":"Cytometry B Clin Cytom"},{"key":"ref16","article-title":"Childhood acute leukemia in West Bengal, India with an emphasis on uncommon clinical features","volume":"10","author":"Biswas S","year":"2009","unstructured":"Biswas S, Chakrabarti S, Chakraborty J, et al.. Childhood acute leukemia in West Bengal, India with an emphasis on uncommon clinical features. Asian Pac J Cancer Prev. 2009, 10:903-906.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.32677\/IJCH.2016.v03.i04.009","article-title":"Clinico-hematological profile of paediatric patient admitted with acute leukemia in tertiary care centre of central India","volume":"3","author":"Kumar S","year":"2016","unstructured":"Kumar S, Anand S, Sahu TP. Clinico-hematological profile of paediatric patient admitted with acute leukemia in tertiary care centre of central India. Indian J Child Health. 2016, 3:308-310. 10.32677\/IJCH.2016.v03.i04.009","journal-title":"Indian J Child Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.53350\/pjmhs20221611496","article-title":"Clinico-pathological features of chronic myelocytic leukemia (CML) in patients presenting at a tertiary care center","volume":"16","author":"Arooj H","year":"2022","unstructured":"Arooj H, Qureshi H, Roghani AS, et al.. Clinico-pathological features of chronic myelocytic leukemia (CML) in patients presenting at a tertiary care center. Pak J Med Health Sci. 2022, 16:496-498. 10.53350\/pjmhs20221611496","journal-title":"Pak J Med Health Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3291.ijcp20252965","article-title":"Clinical, hematological, and flow cytometric correlation of acute leukemia in children: a study from a tertiary pediatric care facility in Hyderabad, Telangana","volume":"12","author":"Munirathinam P","year":"2025","unstructured":"Munirathinam P, Sandanala S, Nanditha A, Madheswaran MK. Clinical, hematological, and flow cytometric correlation of acute leukemia in children: a study from a tertiary pediatric care facility in Hyderabad, Telangana. Int J Contemp Pediatr. 2025, 12:1676-1682. 10.18203\/2349-3291.ijcp20252965","journal-title":"Int J Contemp Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.24953\/turkjpediatr.2025.6171","article-title":"Clinical and laboratory characteristics of children with leukemia: a 34-year single-center experience","volume":"67","author":"\u015eenol HB","year":"2025","unstructured":"\u015eenol HB, T\u00fcfek\u00e7i G\u00fcrocak \u00d6, Y\u0131lmaz \u015e, \u00d6ren H. Clinical and laboratory characteristics of children with leukemia: a 34-year single-center experience. Turk J Pediatr. 2025, 67:559-68. 10.24953\/turkjpediatr.2025.6171","journal-title":"Turk J Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-024-05854-1","article-title":"Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an update","volume":"103","author":"Robak T","year":"2024","unstructured":"Robak T, Pu\u0142a A, Braun M, Robak E. Extramedullary and extranodal manifestations in chronic lymphocytic leukemia - an update. Ann Hematol. 2024, 103:3369-83. 10.1007\/s00277-024-05854-1","journal-title":"Ann Hematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.51253\/pafmj.v72i1.5405","article-title":"Clinicohematological parameters and assessment of post induction status in acute myeloid leukemia - experience at a tertiary care center","volume":"72","author":"Zaidi SA","year":"2022","unstructured":"Zaidi SA, Mahmood A, Mahmood R, et al.. Clinicohematological parameters and assessment of post induction status in acute myeloid leukemia - experience at a tertiary care center. Pak Armed Forces Med J. 2022, 72:150-154. 10.51253\/pafmj.v72i1.5405","journal-title":"Pak Armed Forces Med J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.15850\/ijihs.v7n2.1480","article-title":"Clinical manifestations and hematological profiles of pediatric acute myeloblastic leukemia patients: 3 years observational study in a West Java tertiary hospital, Indonesia","volume":"7","author":"Wiraatmadja A","year":"2019","unstructured":"Wiraatmadja A, Hidayat NS, Sugianli AK. Clinical manifestations and hematological profiles of pediatric acute myeloblastic leukemia patients: 3 years observational study in a West Java tertiary hospital, Indonesia. Int J Integr Health Sci. 2019, 7:61-66. 10.15850\/ijihs.v7n2.1480","journal-title":"Int J Integr Health Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2016.01.002","article-title":"Flowcytometric comparative analysis in acute leukemias between Indian and proposed minimal screening panel","volume":"72","author":"Gupta S","year":"2016","unstructured":"Gupta S, Chatterjee T, Sharma S, et al.. Flowcytometric comparative analysis in acute leukemias between Indian and proposed minimal screening panel. Med J Armed Forces India. 2016, 72:220-30. 10.1016\/j.mjafi.2016.01.002","journal-title":"Med J Armed Forces India"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2024-210022","article-title":"Fifth edition WHO classification: myeloid neoplasms","volume":"78","author":"Chen X","year":"2025","unstructured":"Chen X, Patkar N, Tembhare P, et al.. Fifth edition WHO classification: myeloid neoplasms. J Clin Pathol. 2025, 78:335-45. 10.1136\/jcp-2024-210022","journal-title":"J Clin Pathol"},{"key":"ref26","unstructured":"Floreada.io. Flow cytometry analysis. (2026). Accessed: April 14, 2026: https:\/\/floreada.io\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/480882-clinico-hematological-and-immunophenotypic-profile-of-leukemia-patients-at-a-tertiary-care-center-in-jharkhand-india-a-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:03:45Z","timestamp":1776215025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/480882-clinico-hematological-and-immunophenotypic-profile-of-leukemia-patients-at-a-tertiary-care-center-in-jharkhand-india-a-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.107063","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,14]]}}}